Also listed here: On April 28, 2013, SK3 Group entered into an acquisition agreement to acquire 100% of the general partnership interests of Berkeley BioOrganic Research Laboratories, a California general partnership ("Berkeley BioOrganic") from its four general partners, Dave Hoye, Mary Ann Harrel, D. Allen Gray and Charles ApeI, for 20 million shares of SK3 Group, common stock (5 million shares to each general partner seller). Upon consummation of the transaction, the shares of SK3 Group issued to the general partner sellers will be issued as restricted securities and will contain a legend stating that the shares have not been registered under the Securities Act of 1933, as amended."